跳至主要内容
临床试验/CTRI/2013/06/003786
CTRI/2013/06/003786已完成未知

A randomized double blinded placebo controlled clinical trial to assess the tolerability and efficacy of Lycq® on cholesterol and lipoproteins in subjects with moderately elevated serum cholesterol levels

Edio Healthcare AB0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Healthy as assessed by screening laboratory tests
  • Age 25 to 70
  • Total serum cholesterol level > 5.2 mmol/l, <7.0 mmol/
  • Normal liver, kidney and thyroid function
  • Signed written informed consent

排除标准

  • Participation in a clinical study 30 days prior to screening visit
  • Established /diagnosed phytosterolemia
  • Hypersensitivity towards any of the excipients
  • Consumption of cholesterol lowering medication 1 month prior to screening visit and throughout the study
  • Slimming or medically prescribed diet/prescription to special diet (vegan/gluten-free)
  • Alcohol or substance abuse (More than1 to 2 Drinks for Female and 2to 4 drinks for Males per day), within 6 months prior to or under the study.
  • History of unstable coronary artery disease within the previous 6 months
  • Transient Ischemic Attack (TIA) within 1 year prior to screening
  • Hyper-/hypo-thyroidism
  • Malignant disease, treatment ended less than 12 months prior to study start.
  • Pregnant or attempting to become pregnant or lactating during any period of the study
  • Lack of suitability for participation in the trial, for any reason, as judged by staff at the Investigating party

研究者

发起方
Edio Healthcare AB

相似试验